Exane BNP Paribas Initiates Coverage On Colgate-Palmolive with Outperform Rating, Announces Price Target of $109
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has initiated coverage on Colgate-Palmolive with an Outperform rating and a price target of $109.
June 24, 2024 | 10:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exane BNP Paribas has initiated coverage on Colgate-Palmolive with an Outperform rating and a price target of $109.
The initiation of coverage with an Outperform rating and a price target of $109 by Exane BNP Paribas is likely to positively impact Colgate-Palmolive's stock price in the short term. Analyst ratings and price targets are significant indicators for investors, and a positive outlook from a reputable firm can drive buying interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100